Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/29/2003US20030100607 Thiolalkyl benzoic acid derivatives
05/29/2003US20030100606 6-methoxy-2-naphthylacetic acid derivative as a prodrugs, useful for treatment of inflammation in humans
05/29/2003US20030100605 Methods of treating cancer with angiogenesis inhibitors
05/29/2003US20030100603 Administering to the patient subject to a C-reactive protein associated inflammatory condition, an effective amount of a non-alpha-tocopherol enriched tocopherol
05/29/2003US20030100602 Appetite stimulation and reduction of weight loss in patients suffering from symptomatic hiv infection
05/29/2003US20030100601 Reducing postprandial oxidative stress and associated pathologies by the dietary intake of cocoa procyanidines, such as monomers and/or oligomers of catechin and epicatechin
05/29/2003US20030100600 Method for treating atherosclerosis or restenosis using microtubule stabilizing agent
05/29/2003US20030100599 2-amino-fluorene derivatives useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with alpha 4 intergrins or their ligands
05/29/2003US20030100598 Novel esters derived from (rr,ss)-2-hydroxybenzoate of 3-(2-dimethylaminomethyl-1-hydroxycyclohexyl)phenyl
05/29/2003US20030100597 Novel indole derivatives and their use as medicaments
05/29/2003US20030100596 Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles
05/29/2003US20030100595 Oral dosage form of a sulfonamide prodrug
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100592 Benzimidazole derivatives and salts and prodrugs thereof; treatment of cancers or viral infections
05/29/2003US20030100591 Administering inhibitor of cyclooxygenase-2, inhibitor of prostaglandin E synthase, or EP2 or EP4 receptor antagonist; for uterine cancer, fibroids or endometriosis
05/29/2003US20030100588 Indole-type inhibitors of p38 kinase
05/29/2003US20030100587 New substituted 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them
05/29/2003US20030100586 Agent for controlling animal diseases caused by parasites
05/29/2003US20030100585 For example 3-(2-(1-(2-(3-Methoxy-4-(3-o-tolyl-ureido)-phenyl)-acetylamino )- 3-methyl-butyl)-4,5-dihydro-oxazol-5-yl)-2-methyl-propionic acid
05/29/2003US20030100584 Highly selective inhibitors of the urokinase plasminogen activator
05/29/2003US20030100582 Benzimidazole compounds for regulating IgE
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/29/2003US20030100579 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
05/29/2003US20030100578 For example, (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7H-8,9 -dihydro-pyrano-(2,3-c)imidazo(1,2-a)pyridine
05/29/2003US20030100577 Neurotrophic agents in treatment of solid tumors and vascular disease
05/29/2003US20030100575 Derivatives of barbituric and thiobarbituric acids; rapidly metabolized by blood and tissue enzymes to form polar metabolites with no hypnotic activity and which are rapidly eliminated
05/29/2003US20030100574 Tricyclic 3,4-propinoperhydropurines; uses thereof for blocking neuronal transmission
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100569 Anti-mycobacterial compounds
05/29/2003US20030100568 Polymorphic form of itraconazole
05/29/2003US20030100567 Tyrosine kinase inhibitors
05/29/2003US20030100566 Sustained release ranolazine formulations
05/29/2003US20030100565 Method for the treatment or prevention of atopic dermatitis
05/29/2003US20030100564 Administering 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione and/or metabolite thereof; treating neoplastic diseases, atherosclerosis, restenosis, rheumatoid arthritis, Crohn's disease, diabetic retinopathy, psoriasis, and endometriosis
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100558 Such as 4-(4-fluorophenyl)-5-(2-phenylmethylamino)pyrimidin-4-yl)-1-ethoxymethyl -(1,2,3)triazole for inhibition of release of inflammatory interleukins; for treatment of osteoarthritis, rheumatoid arthritis, and congestive heart failure
05/29/2003US20030100556 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders
05/29/2003US20030100553 Farnesyl protein transferase inhibitor combinations with camptothecin compounds
05/29/2003US20030100551 Production of apoptotic films for direct contact with tumors
05/29/2003US20030100548 Antiarthritic agents; atherosclerosis and chronic obstructive pulmonary disease treatments
05/29/2003US20030100547 Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies
05/29/2003US20030100545 Psychological disorder treatments that increase the activity of cholinergic receptors
05/29/2003US20030100544 Inhibiting tubulin polymerization; treating prostate and breast cancer
05/29/2003US20030100543 Novel steroids containing a 14 beta ,15 beta - cyclopropane ring and a 17 alpha hydroxymethyl group; male contraceptives
05/29/2003US20030100542 5-hydroxysapogenin derivatives with anti-dementia activity
05/29/2003US20030100541 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein
05/29/2003US20030100540 Identification of NSAID-regulated genes
05/29/2003US20030100539 Metabotropic glutamate receptors (mGluR); treating fragile X, autism, mental retardation, schizophrenia and Down's Syndrome
05/29/2003US20030100538 Substituted chalcones as therapeutic compounds
05/29/2003US20030100537 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate
05/29/2003US20030100536 Treating a herpes virus, atherosclerosis or restenosis
05/29/2003US20030100535 Administering a compound which binds to a galectin
05/29/2003US20030100534 Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products
05/29/2003US20030100533 Drug combination for the treatment of viral diseases
05/29/2003US20030100532 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
05/29/2003US20030100527 Immunostimulatory nucleic acid molecules for activating dendritic cells
05/29/2003US20030100521 For therapy of HIV infection
05/29/2003US20030100518 13-Methyl erythromycin derivatives
05/29/2003US20030100517 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role
05/29/2003US20030100516 Analgesic agent
05/29/2003US20030100515 Benzophenone glycopyranosides, preparation and therapeutic use
05/29/2003US20030100514 Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
05/29/2003US20030100513 Methods and compositions for increasing the anaerobic working capacity in tissues
05/29/2003US20030100509 Injectable solution of an LHRH antagonist
05/29/2003US20030100507 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain
05/29/2003US20030100505 Concurrent therapy with insulin-like growth factor I (IGF-I) variant thereof and glycosaminoglycan, wherein concurrent therapy promotes a desired therapeutic response
05/29/2003US20030100504 Treatment and diagnosis of insulin-resistant states
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/29/2003US20030100488 Osteoprotegerin binding proteins
05/29/2003US20030100487 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/29/2003US20030100481 Agents for combating Neospora spec
05/29/2003US20030100478 Articles of manufacture
05/29/2003US20030100477 Medicinal compositions for suppressing beta-amyloid production
05/29/2003US20030100115 Killing cells that lack tumor suppressor proteins; obtain cells, transform with preferential single stranded nucleotide sequence, monitor viability of cells
05/29/2003US20030100097 Propagation of microorganism genetically engineered to produce food products; obtain cells, incoulate nutrient broth containing sodium sulfate, ferment, recover food product
05/29/2003US20030100083 Preparation of pseudomonic acid A; obtain bacteria capable of producing pseudomonic acid A, culture, ferment and isolate pseudomonic acid A from culture
05/29/2003US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis
05/29/2003US20030100042 Altering a pathway of fatty acid synthesis in a bacterium with a phenol derivative
05/29/2003US20030100018 Mass-based encoding and qualitative analysis of combinatorial libraries
05/29/2003US20030100017 Prevention of microorganismal infections; obtain sample of microorganism, incubate with tetracycline compound, monitor propagation of microorganism, reduced propagation indicates effective fungicide
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099980 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, and inflammamtory diseases
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099960 Compositions and methods for optimizing UGT2B7 substrate dosings and for predicting UGT2B7 substrate toxicity
05/29/2003US20030099959 Cooperative oligonucleotides
05/29/2003US20030099944 Combination therapy involving drugs which target cellular proteins and drugs which target pathogen-encoded proteins
05/29/2003US20030099756 Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099732 Proteoglycan Compositions for Treating Prostate and Bladder Inflammatory Conditions
05/29/2003US20030099728 Anti-aromatase composition
05/29/2003US20030099727 Compositions and methods for reducing cytotoxicity and inhibiting angiogenesis
05/29/2003US20030099726 Medicine comprises Echinacea phytochemicals and benzalkonium chloride in a sterile water solution; for therapy
05/29/2003US20030099725 For therapy and prophylaxis of cancers especially cancer of lung, esophagus, stomach, oral cavity and prostate as well as for therapy of Helicobacter pylori infection; useful as adjuncts to conventional surgery or radiotherapy
05/29/2003US20030099724 Compounds for prevention of diabetic retinopathy
05/29/2003US20030099723 Method for the prevention or treatment of hypomagnesemia in pediatric patients and in patients with g-tubes or ng-tubes
05/29/2003US20030099722 Methods and compositions for providing glutamine
05/29/2003US20030099719 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
05/29/2003US20030099712 Therapeutic coating for an intravascular implant
05/29/2003US20030099711 Sustained release preparations
1 ... 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 5467 5468 5469 5470 5471 5472 5473 ... 7860